TSC2 and angiomyolipoma: Two angiomyolipomas (S16 and S28) from this patient had no evidence of TSC2 LOH, nor any confirmed somatic mutations, suggesting alternate mechanisms of TSC2 loss not detected by our analysis, or potential low tumor purity.